fine-tuning biomarker testing to identify and target ret fusions in nsclc
Published 1 year ago • 163 plays • Length 1:14:14Download video MP4
Download video MP3
Similar videos
-
1:39:03
everything you need to know about biomarker testing and treatment of genomically altered nsclc
-
10:28
candid conversations in lung cancer: discussing biomarker testing and targeted therapies
-
1:37:00
find the targets, treat with precision: modern principles and new advances in biomarker-driven nsclc
-
59:37
refining biomarker testing and targeted treatment of nsclc with egfr mutations
-
1:13:59
perfecting precision in nsclc practice: are you optimally integrating biomarker-driven therapy?
-
49:54
practical principles of biomarker testing in advanced non-small cell lung cancer
-
45:50
practical principles of biomarker testing in advanced non-small cell lung cancer
-
5:50
what challenges surround lung cancer biomarker testing?
-
6:32
what is the preferred molecular testing method to detect ret in nsclc?
-
1:01:46
biomarkers, immunotherapies, combinations, and other emerging approaches for lung cancer
-
0:52
genomic testing is necessary in non-small cell lung cancer
-
28:23
biomarkers, immunotherapies, combinations, and other emerging approaches for lung cancer
-
7:00
landscape of biomarker testing for nsclc
-
4:58
treatment of nsclc with ret fusions
-
4:18
when should biomarker testing be done in nsclc?
-
2:12
the impact of selpercatinib in patients with ret fusion-positive nsclc
-
2:21
dr sabari on barriers to biomarker testing in nsclc
-
5:50
how is biomarker testing carried out?
-
12:26
the significance of biomarker testing in patient identification